EUVIMEDEUVIMED entdecken
Crossref

Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model

James E Chessum, Shana A Shaya, Dana Rajab, Ali Aftabjahani, Ji Zhou, Jeffrey I Weitz, Peter L Gross, Paul Y Kim

Journal of Thrombosis and Haemostasis · 2024-01 · 22 (1) · 263-270

DOI: 10.1016/j.jtha.2023.09.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024-01. Verfasst von James E Chessum und 7 weiteren Autor:innen. Beteiligte Einrichtung: Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Carboxypeptidase B2, Venous Thromboembolism, Pulmonary Embolism, Thrombosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: McMaster University, Department of Medicine, Georgetown University, Heart and Stroke Foundation of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Thrombin-activatable fibrinolysis inhibitor (TAFI) levels are positively correlated with the risk of thrombosis. The mechanism of how TAFI affects venous thromboembolism (VTE) remains uncertain. In addition, the role of sex on the risk of VTE has also been studied. However, their association also remains unclear. OBJECTIVES: To investigate how TAFI and/or sex affect venous thrombus stability and consequent pulmonary embolism (PE). METHODS: Ferric chloride-induced thrombi were formed within the femoral veins of male and female wild-type (WT) or TAFI-knockout (Cpb2-/-) mice. Thrombi were imaged over 2 hours using intravital videomicroscopy to quantify embolization and thrombus size over time. Lungs were examined by immunohistochemistry to quantify (a) emboli and (b) fibrin composition of these emboli. RESULTS: Embolization events in female mice were higher than in males (7.9-fold in WT and 3.1-fold in Cpb2-/- mice). Although the maximal thrombus sizes were not different across groups, Cpb2-/- mice had thrombi that were, on average, 24% smaller at the end of the 2-hour experiment than WT mice. Loss of TAFI led to a 4.0- and 2.8-fold increase in PE burden in males and females, respectively, while sex had no influence. Pulmonary emboli in Cpb2-/- mice had higher fibrin composition compared with WT mice. CONCLUSION: Female mice had less stable venous thrombi than male mice, suggesting a higher risk of PE in females with deep vein thrombosis. Mice lacking TAFI had more thrombus degradation and higher PE burden than WT mice. These results confirm the role of TAFI in venous thrombosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carboxypeptidase B2Venous ThromboembolismPulmonary EmbolismThrombosisMaleFemaleMiceAnimalsDisease Models, AnimalFibrinFibrinolysis

Stichwörter der Autor:innen

fibrinolysismicroscopy videopulmonary embolismthrombosisvenous thromboembolism

Substanzen

Carboxypeptidase B2FibrinCpb2 protein, mouse

Autor:innen und Institutionen

  • Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada.
  • Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Biochemistry and Biomedical Sciences, McMaster Universi…
  • Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: paul.kim@taari.ca.

Förderung

  • McMaster University
  • Department of Medicine, Georgetown University
  • Heart and Stroke Foundation of Canada
  • Canada Research Chairs

Zitieren

APA

Chessum, J. E., Shaya, S. A., Rajab, D., Aftabjahani, A., Zhou, J., Weitz, J. I., Gross, P. L., & Kim, P. Y. (2024). Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model. Journal of Thrombosis and Haemostasis, 22(1), 263-270. https://doi.org/10.1016/j.jtha.2023.09.016

Vancouver

Chessum JE, Shaya SA, Rajab D, Aftabjahani A, Zhou J, Weitz JI, et al. Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model. Journal of Thrombosis and Haemostasis. 2024;22(1):263-270. doi:10.1016/j.jtha.2023.09.016

BibTeX
@article{Chessum2024,
  author = {Chessum, James E and Shaya, Shana A and Rajab, Dana and Aftabjahani, Ali and Zhou, Ji and Weitz, Jeffrey I and Gross, Peter L and Kim, Paul Y},
  title = {Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  volume = {22},
  number = {1},
  pages = {263--270},
  doi = {10.1016/j.jtha.2023.09.016}
}
Kostenlos starten →